Cargando…

Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation

Latent Epstein-Barr virus (EBV) infection can clinically reactivate in immunosuppressed individuals causing lymphoproliferative disease and rarely hepatitis. In this study, we provide in vivo and in vitro evidence that Treponema pallidum infection can cause EBV reactivation with hepatitis in an immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirsiger, Julia R, Fuchs, Philipp S, Häusermann, Peter, Müller-Durovic, Bojana, Daikeler, Thomas, Recher, Mike, Hirsch, Hans H, Terracciano, Luigi, Berger, Christoph T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736073/ https://www.ncbi.nlm.nih.gov/pubmed/31660400 http://dx.doi.org/10.1093/ofid/ofz317

Ejemplares similares

Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
por: Valente, Robert M., et al.
Publicado: (2012)

Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion
por: Hirsiger, Julia R., et al.
Publicado: (2023)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination
por: Recher, Mike, et al.
Publicado: (2018)

Toll-Like Receptor Gene Polymorphisms and Susceptibility to Epstein–Barr Virus-Associated and -Negative Gastric Carcinoma in Northern China
por: Liu, Shuzhen, et al.
Publicado: (2015)

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
por: Cho, Hyun-Il, et al.
Publicado: (2018)

Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal Carcinoma
por: Sheen, Tzung‐Shiahn, et al.
Publicado: (1999)

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )
por: Huisman, Wesley, et al.
Publicado: (2020)

Characterization of an Epstein-Barr virus receptor on human epithelial cells
Publicado: (1992)

Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes
por: Farina, Antonella, et al.
Publicado: (2017)

The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein–Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis
por: Smarz-Widelska, Iwona, et al.
Publicado: (2022)

How Toll-like Receptor 9 Plays a Key Role in the Development of Gastric Cancer and Is Linked to Epstein–Barr Virus Infection
por: Majewski, Marek, et al.
Publicado: (2023)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
por: Chen, Jia, et al.
Publicado: (2018)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Latent Syphilis
Publicado: (1864)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
por: van Gent, Michiel, et al.
Publicado: (2014)

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients
por: Fuchs, Philipp S., et al.
Publicado: (2020)

Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
por: Yang, Dongchang, et al.
Publicado: (2011)

Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus
por: Petrara, Maria Raffaella, et al.
Publicado: (2017)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

Role of Cytokines and Toll-Like Receptors in the Immunopathogenesis of Guillain-Barré Syndrome
por: Nyati, Kishan Kumar, et al.
Publicado: (2014)

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
por: Iwakiri, Dai, et al.
Publicado: (2009)

Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9
por: Salloum, Noor, et al.
Publicado: (2018)

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
por: Kanekiyo, Masaru, et al.
Publicado: (2015)

Regulation of B cell receptor signalling by Epstein–Barr virus nuclear antigens
por: Khasnis, Sarika, et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Latent Syphilis in the Tropics
Publicado: (1938)

Latent Syphilis in the Tropics
por: Greval, S. D. S., et al.
Publicado: (1938)

Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1
por: Webb, Natasha, et al.
Publicado: (2008)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells
por: Xu, Jing-xiao, et al.
Publicado: (2023)

Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis
por: Schneider-Hohendorf, Tilman, et al.
Publicado: (2022)

The reservoir of latent HIV
por: Chen, Jing, et al.
Publicado: (2022)

Secretion of Epstein-Barr Virus-encoded BARF1 oncoprotein from latently infected B cells
por: Fiorini, Sylvie, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r3au95b5va71g204kares8qeop